Neurocrine Biosciences, Inc. (FRA:NB3)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,941	13,349	11,712	10,744	7,105	7,321
Market Cap Growth	6.77%	13.98%	9.01%	51.23%	-2.96%	-17.01%
Enterprise Value	12,394	12,439	10,969	10,261	6,829	6,972
Last Close Price	130.10	132.80	118.85	111.94	73.88	75.86
PE Ratio	35.47	40.49	51.85	74.32	90.18	21.99
PS Ratio	5.66	5.87	6.86	7.71	7.13	8.56
PB Ratio	5.05	5.34	5.80	6.72	5.88	7.95
P/TBV Ratio	5.12	5.43	5.91	6.90	5.88	7.95
P/FCF Ratio	25.60	24.80	35.80	35.56	34.66	41.15
P/OCF Ratio	23.84	23.21	33.20	33.83	31.50	39.19
EV/Sales Ratio	5.37	5.47	6.43	7.37	6.85	8.15
EV/EBITDA Ratio	22.82	21.11	29.14	41.44	35.51	25.37
EV/EBIT Ratio	26.67	22.09	30.71	44.04	37.38	26.04
EV/FCF Ratio	24.52	23.11	33.53	33.96	33.32	39.19
Debt / Equity Ratio	0.16	0.19	0.19	0.15	0.32	0.37
Debt / EBITDA Ratio	0.76	0.76	0.99	0.94	1.88	1.19
Debt / FCF Ratio	0.81	0.89	1.19	0.81	1.89	1.90
Asset Turnover	0.69	0.68	0.67	0.67	0.60	0.69
Inventory Turnover	17.15	15.99	16.48	14.85	11.71	12.59
Quick Ratio	2.89	3.06	2.25	2.49	3.65	5.14
Current Ratio	3.38	3.40	2.45	2.70	3.96	5.45
Return on Equity (ROE)	14.96%	14.16%	12.68%	10.03%	7.17%	46.20%
Return on Assets (ROA)	8.66%	10.46%	8.78%	7.01%	6.82%	13.46%
Return on Capital (ROIC)	10.41%	12.68%	10.66%	8.22%	7.75%	15.33%
Return on Capital Employed (ROCE)	14.90%	18.20%	15.20%	13.60%	11.40%	21.20%
Earnings Yield	2.82%	2.47%	1.93%	1.35%	1.11%	4.55%
FCF Yield	3.91%	4.03%	2.79%	2.81%	2.89%	2.43%
Buyback Yield / Dilution	1.30%	-2.67%	-2.12%	-1.02%	-0.10%	-2.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.